CLOs on the Move

Anesthesia Service Inc

www.anesthesiaservice.com

 
Anesthesia Service Inc is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Vizer

Vizer is an exercise rewards app that allows you to donate meals and earn points towards rewards at local businesses. Learn more and get started today!

Woodcrest Commons

Woodcrest Commons is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Woodcrest Commons is based in Rochester, NY. You can find more information on Woodcrest Commons at www.depaul.org

Teladoc Health

Teladoc Health is on a mission to empower all people everywhere to live healthier lives by transforming the healthcare experience. Recognized as the world leader in whole-person virtual care, Teladoc Health addresses the full spectrum of health and well-being — powered by human expertise, advanced technology and insights—to deliver improved clinical outcomes at scale. Serving more than 175 countries and ranked Best in KLAS for Virtual Care Platforms in 2020, Teladoc Health leverages extensive expertise and data-driven insights to meet the growing healthcare needs of consumers and healthcare professionals.

AmRelieve

AmRelieve is a multinational eCommerce business operating in the health and wellbeing industry, with a focus on serving active seniors in pain free living. They offer a range of natural health products, including CBD balms and gummies, lumbar support b...

Questcor

We are a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Our efforts are currently focused on the fields of neurology, nephrology and rheumatology, areas of medicine which have significant unmet medical needs. Our main product is H.P Acthar® Gel (repository corticotropin injection), a naturally-derived formulation of adrenocorticotropic hormones used in a variety of disorders having an inflammatory component. We are currently supporting research in a number of rare conditions, where there is significant unmet need for treatment alternatives to standard therapies. We are also actively supporting research efforts to better understand disease processes and therapeutic mechanisms of action in conditions where Acthar might potentially play a role in treatment.